23,067 Fresh COVID-19 Cases In India, 6.6 Per Cent Lower Than Yesterday Coronavirus: Active COVID-19 cases in India have been on a steady decline for a month; positivity rate drops in states with high daily infection numbers.
Updated: December 25, 2020 11:44 am IST
Coronavirus: India s COVID-19 tally crossed the one-crore mark on December 18.
New Delhi: India continued to log more coronavirus recoveries than fresh COVID-19 infections, which rose by 23,067 in the last 24 hours, government data shows. Some 24,661 people fought off Covid in this period while 336 people died of the illnesses. With this, the country s total coronavirus cases shot to one crore, one lakh and 46 thousand with 1,47,092 deaths, so far. Country s active coronavirus cases - or those still receiving medical attention - dropped further to 2.81 lakh.
The first 2 approved vaccines are offering hope that the beginning of the end of this global health emergency is at hand, even as the virus offers disquieting reminders that it is not static.
Coronavirus mutations identified in the United Kingdom and South Africa may be provoking alarm, but infectious-disease experts are optimistic the new variants are still vulnerable to the powerful hammer of newly authorized vaccines. Even if the virus were to mutate further, the experts say, the vaccines could be rapidly reprogrammed to remain effective against new variants.
By JOEL ACHENBACH | The Washington Post | Published: December 24, 2020
Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription. Coronavirus mutations identified in the United Kingdom and South Africa may be provoking alarm, but infectious-disease experts are optimistic the new variants are still vulnerable to the powerful hammer of newly authorized vaccines. Even if the virus were to mutate further, the experts say, the vaccines could be rapidly reprogrammed to remain effective against new variants. Such a tweaking of the vaccines could be done in minutes, said Drew Weissman, a professor of medicine at the University of Pennsylvania s Perelman School of Medicine and one of the inventors of the messenger RNA technology that powers both vaccines.